ATAI Life Sciences takes on opioid crisis by acquiring Kures to develop novel therapeutics for opioid abuse

NEWS PROVIDED BY ATAI Life Sciences  Jul 09, 2020, 12:30 ET BERLIN and NEW YORK, July 9, 2020 /PRNewswire/ -- ATAI Life Sciences AG, a global biotechnology company builder that envisions an end to mental…

Continue Reading ATAI Life Sciences takes on opioid crisis by acquiring Kures to develop novel therapeutics for opioid abuse

IntelGenx and Cybin Corp. Enter Into Feasibility Agreement for Fast-Acting, Orally-Dissolving Psilocybin Film

July 07, 2020 08:00 ET | Source: IntelGenx Technologies Corp. SAINT LAURENT, Quebec, July 07, 2020 (GLOBE NEWSWIRE) -- IntelGenx Corp. (TSX-V:IGX) (OTCQB:IGXT) (“IntelGenx”), a leader in pharmaceutical films, is pleased to announce…

Continue Reading IntelGenx and Cybin Corp. Enter Into Feasibility Agreement for Fast-Acting, Orally-Dissolving Psilocybin Film

Mydecine Innovations Group Adds World Renowned, 7-Time Nobel Peace Prize Nominee Dr. M.S Reddy to its Scientific Advisory Board

NEWS PROVIDED BY Mydecine Innovations Group Inc.  07 Jul, 2020, 05:30 BST VANCOUVER, British Columbia, July 7, 2020 /PRNewswire/ -- Mydecine Innovations Group Inc. (CSE: MYCO) (OTC: MYCOF) (FSE:0NF) ("Mydecine" or the…

Continue Reading Mydecine Innovations Group Adds World Renowned, 7-Time Nobel Peace Prize Nominee Dr. M.S Reddy to its Scientific Advisory Board